img

Global Irritable Bowel Syndrome Drug Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Irritable Bowel Syndrome Drug Market Insights, Forecast to 2034

Market Analysis and InsightsGlobal Irritable Bowel Syndrome Drug Market
Global Irritable Bowel Syndrome Drug market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022. Backed with the increasing demand from downstream industries, Irritable Bowel Syndrome Drug industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
Globally, Irritable Bowel Syndrome Drug key companies include Ironwood Pharmaceuticals, Bausch Health, Takeda, Sebela Pharmaceuticals and Allergan, etc. Ironwood Pharmaceuticals, Bausch Health, Takeda are top 3 players and held % share in total in 2022.
When considering the consumption regions, % revenue of Irritable Bowel Syndrome Drug were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029 and the share will be % in 2029. Moreover, China, plays a key role in the whole Irritable Bowel Syndrome Drug market and estimated to attract more attentions from industry insiders and investors.
Irritable Bowel Syndrome Drug can be divided into IBS-D Drugs, IBS-C Drugs and Others,, etc. IBS-D Drugs is the mainstream product in the market, accounting for % revenue share globally in 2022 and the proportion will be % in 2029.
Irritable Bowel Syndrome Drug is widely used in various fields, such as Women and Men, etc. Women provides greatest supports to the Irritable Bowel Syndrome Drug industry development. In 2022, global % revenue of Irritable Bowel Syndrome Drug went into Women filed and the proportion will reach to % in 2029.
Report Covers
This report presents an overview of global Irritable Bowel Syndrome Drug market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Irritable Bowel Syndrome Drug market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Ironwood Pharmaceuticals
Bausch Health
Takeda
Sebela Pharmaceuticals
Allergan
Segment by Type
IBS-D Drugs
IBS-C Drugs
Others

Segment by Application


Women
Men
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, Irritable Bowel Syndrome Drug introduction, etc. Irritable Bowel Syndrome Drug Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports’s Conclusions of Irritable Bowel Syndrome Drug
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Irritable Bowel Syndrome Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 IBS-D Drugs
1.2.3 IBS-C Drugs
1.2.4 Others
1.3 Market by Application
1.3.1 Global Irritable Bowel Syndrome Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Women
1.3.3 Men
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Irritable Bowel Syndrome Drug Market Perspective (2018-2029)
2.2 Global Irritable Bowel Syndrome Drug Growth Trends by Region
2.2.1 Irritable Bowel Syndrome Drug Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Irritable Bowel Syndrome Drug Historic Market Size by Region (2018-2024)
2.2.3 Irritable Bowel Syndrome Drug Forecasted Market Size by Region (2024-2029)
2.3 Irritable Bowel Syndrome Drug Market Dynamics
2.3.1 Irritable Bowel Syndrome Drug Industry Trends
2.3.2 Irritable Bowel Syndrome Drug Market Drivers
2.3.3 Irritable Bowel Syndrome Drug Market Challenges
2.3.4 Irritable Bowel Syndrome Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Irritable Bowel Syndrome Drug by Players
3.1.1 Global Irritable Bowel Syndrome Drug Revenue by Players (2018-2024)
3.1.2 Global Irritable Bowel Syndrome Drug Revenue Market Share by Players (2018-2024)
3.2 Global Irritable Bowel Syndrome Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Irritable Bowel Syndrome Drug, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Irritable Bowel Syndrome Drug Market Concentration Ratio
3.4.1 Global Irritable Bowel Syndrome Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Irritable Bowel Syndrome Drug Revenue in 2022
3.5 Global Key Players of Irritable Bowel Syndrome Drug Head office and Area Served
3.6 Global Key Players of Irritable Bowel Syndrome Drug, Product and Application
3.7 Global Key Players of Irritable Bowel Syndrome Drug, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Irritable Bowel Syndrome Drug Breakdown Data by Type
4.1 Global Irritable Bowel Syndrome Drug Historic Market Size by Type (2018-2024)
4.2 Global Irritable Bowel Syndrome Drug Forecasted Market Size by Type (2024-2029)
5 Irritable Bowel Syndrome Drug Breakdown Data by Application
5.1 Global Irritable Bowel Syndrome Drug Historic Market Size by Application (2018-2024)
5.2 Global Irritable Bowel Syndrome Drug Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Irritable Bowel Syndrome Drug Market Size (2018-2029)
6.2 North America Irritable Bowel Syndrome Drug Market Size by Type
6.2.1 North America Irritable Bowel Syndrome Drug Market Size by Type (2018-2024)
6.2.2 North America Irritable Bowel Syndrome Drug Market Size by Type (2024-2029)
6.2.3 North America Irritable Bowel Syndrome Drug Market Share by Type (2018-2029)
6.3 North America Irritable Bowel Syndrome Drug Market Size by Application
6.3.1 North America Irritable Bowel Syndrome Drug Market Size by Application (2018-2024)
6.3.2 North America Irritable Bowel Syndrome Drug Market Size by Application (2024-2029)
6.3.3 North America Irritable Bowel Syndrome Drug Market Share by Application (2018-2029)
6.4 North America Irritable Bowel Syndrome Drug Market Size by Country
6.4.1 North America Irritable Bowel Syndrome Drug Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Irritable Bowel Syndrome Drug Market Size by Country (2018-2024)
6.4.3 North America Irritable Bowel Syndrome Drug Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Irritable Bowel Syndrome Drug Market Size (2018-2029)
7.2 Europe Irritable Bowel Syndrome Drug Market Size by Type
7.2.1 Europe Irritable Bowel Syndrome Drug Market Size by Type (2018-2024)
7.2.2 Europe Irritable Bowel Syndrome Drug Market Size by Type (2024-2029)
7.2.3 Europe Irritable Bowel Syndrome Drug Market Share by Type (2018-2029)
7.3 Europe Irritable Bowel Syndrome Drug Market Size by Application
7.3.1 Europe Irritable Bowel Syndrome Drug Market Size by Application (2018-2024)
7.3.2 Europe Irritable Bowel Syndrome Drug Market Size by Application (2024-2029)
7.3.3 Europe Irritable Bowel Syndrome Drug Market Share by Application (2018-2029)
7.4 Europe Irritable Bowel Syndrome Drug Market Size by Country
7.4.1 Europe Irritable Bowel Syndrome Drug Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Irritable Bowel Syndrome Drug Market Size by Country (2018-2024)
7.4.3 Europe Irritable Bowel Syndrome Drug Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Irritable Bowel Syndrome Drug Market Size (2018-2029)
8.2 China Irritable Bowel Syndrome Drug Market Size by Type
8.2.1 China Irritable Bowel Syndrome Drug Market Size by Type (2018-2024)
8.2.2 China Irritable Bowel Syndrome Drug Market Size by Type (2024-2029)
8.2.3 China Irritable Bowel Syndrome Drug Market Share by Type (2018-2029)
8.3 China Irritable Bowel Syndrome Drug Market Size by Application
8.3.1 China Irritable Bowel Syndrome Drug Market Size by Application (2018-2024)
8.3.2 China Irritable Bowel Syndrome Drug Market Size by Application (2024-2029)
8.3.3 China Irritable Bowel Syndrome Drug Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Irritable Bowel Syndrome Drug Market Size (2018-2029)
9.2 Asia Irritable Bowel Syndrome Drug Market Size by Type
9.2.1 Asia Irritable Bowel Syndrome Drug Market Size by Type (2018-2024)
9.2.2 Asia Irritable Bowel Syndrome Drug Market Size by Type (2024-2029)
9.2.3 Asia Irritable Bowel Syndrome Drug Market Share by Type (2018-2029)
9.3 Asia Irritable Bowel Syndrome Drug Market Size by Application
9.3.1 Asia Irritable Bowel Syndrome Drug Market Size by Application (2018-2024)
9.3.2 Asia Irritable Bowel Syndrome Drug Market Size by Application (2024-2029)
9.3.3 Asia Irritable Bowel Syndrome Drug Market Share by Application (2018-2029)
9.4 Asia Irritable Bowel Syndrome Drug Market Size by Region
9.4.1 Asia Irritable Bowel Syndrome Drug Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Irritable Bowel Syndrome Drug Market Size by Region (2018-2024)
9.4.3 Asia Irritable Bowel Syndrome Drug Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Irritable Bowel Syndrome Drug Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Irritable Bowel Syndrome Drug Market Size by Type
10.2.1 Middle East, Africa, and Latin America Irritable Bowel Syndrome Drug Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Irritable Bowel Syndrome Drug Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Irritable Bowel Syndrome Drug Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Irritable Bowel Syndrome Drug Market Size by Application
10.3.1 Middle East, Africa, and Latin America Irritable Bowel Syndrome Drug Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Irritable Bowel Syndrome Drug Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Irritable Bowel Syndrome Drug Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Irritable Bowel Syndrome Drug Market Size by Country
10.4.1 Middle East, Africa, and Latin America Irritable Bowel Syndrome Drug Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Irritable Bowel Syndrome Drug Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Irritable Bowel Syndrome Drug Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Ironwood Pharmaceuticals
11.1.1 Ironwood Pharmaceuticals Company Details
11.1.2 Ironwood Pharmaceuticals Business Overview
11.1.3 Ironwood Pharmaceuticals Irritable Bowel Syndrome Drug Introduction
11.1.4 Ironwood Pharmaceuticals Revenue in Irritable Bowel Syndrome Drug Business (2018-2024)
11.1.5 Ironwood Pharmaceuticals Recent Developments
11.2 Bausch Health
11.2.1 Bausch Health Company Details
11.2.2 Bausch Health Business Overview
11.2.3 Bausch Health Irritable Bowel Syndrome Drug Introduction
11.2.4 Bausch Health Revenue in Irritable Bowel Syndrome Drug Business (2018-2024)
11.2.5 Bausch Health Recent Developments
11.3 Takeda
11.3.1 Takeda Company Details
11.3.2 Takeda Business Overview
11.3.3 Takeda Irritable Bowel Syndrome Drug Introduction
11.3.4 Takeda Revenue in Irritable Bowel Syndrome Drug Business (2018-2024)
11.3.5 Takeda Recent Developments
11.4 Sebela Pharmaceuticals
11.4.1 Sebela Pharmaceuticals Company Details
11.4.2 Sebela Pharmaceuticals Business Overview
11.4.3 Sebela Pharmaceuticals Irritable Bowel Syndrome Drug Introduction
11.4.4 Sebela Pharmaceuticals Revenue in Irritable Bowel Syndrome Drug Business (2018-2024)
11.4.5 Sebela Pharmaceuticals Recent Developments
11.5 Allergan
11.5.1 Allergan Company Details
11.5.2 Allergan Business Overview
11.5.3 Allergan Irritable Bowel Syndrome Drug Introduction
11.5.4 Allergan Revenue in Irritable Bowel Syndrome Drug Business (2018-2024)
11.5.5 Allergan Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Irritable Bowel Syndrome Drug Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of IBS-D Drugs
Table 3. Key Players of IBS-C Drugs
Table 4. Key Players of Others
Table 5. Global Irritable Bowel Syndrome Drug Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 6. Global Irritable Bowel Syndrome Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Irritable Bowel Syndrome Drug Market Size by Region (2018-2024) & (US$ Million)
Table 8. Global Irritable Bowel Syndrome Drug Market Share by Region (2018-2024)
Table 9. Global Irritable Bowel Syndrome Drug Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Irritable Bowel Syndrome Drug Market Share by Region (2024-2029)
Table 11. Irritable Bowel Syndrome Drug Market Trends
Table 12. Irritable Bowel Syndrome Drug Market Drivers
Table 13. Irritable Bowel Syndrome Drug Market Challenges
Table 14. Irritable Bowel Syndrome Drug Market Restraints
Table 15. Global Irritable Bowel Syndrome Drug Revenue by Players (2018-2024) & (US$ Million)
Table 16. Global Irritable Bowel Syndrome Drug Revenue Share by Players (2018-2024)
Table 17. Global Top Irritable Bowel Syndrome Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Irritable Bowel Syndrome Drug as of 2022)
Table 18. Global Irritable Bowel Syndrome Drug Industry Ranking 2021 VS 2022 VS 2024
Table 19. Global 5 Largest Players Market Share by Irritable Bowel Syndrome Drug Revenue (CR5 and HHI) & (2018-2024)
Table 20. Global Key Players of Irritable Bowel Syndrome Drug, Headquarters and Area Served
Table 21. Global Key Players of Irritable Bowel Syndrome Drug, Product and Application
Table 22. Global Key Players of Irritable Bowel Syndrome Drug, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Irritable Bowel Syndrome Drug Market Size by Type (2018-2024) & (US$ Million)
Table 25. Global Irritable Bowel Syndrome Drug Revenue Market Share by Type (2018-2024)
Table 26. Global Irritable Bowel Syndrome Drug Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Irritable Bowel Syndrome Drug Revenue Market Share by Type (2024-2029)
Table 28. Global Irritable Bowel Syndrome Drug Market Size by Application (2018-2024) & (US$ Million)
Table 29. Global Irritable Bowel Syndrome Drug Revenue Share by Application (2018-2024)
Table 30. Global Irritable Bowel Syndrome Drug Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Irritable Bowel Syndrome Drug Revenue Share by Application (2024-2029)
Table 32. North America Irritable Bowel Syndrome Drug Market Size by Type (2018-2024) & (US$ Million)
Table 33. North America Irritable Bowel Syndrome Drug Market Size by Type (2024-2029) & (US$ Million)
Table 34. North America Irritable Bowel Syndrome Drug Market Size by Application (2018-2024) & (US$ Million)
Table 35. North America Irritable Bowel Syndrome Drug Market Size by Application (2024-2029) & (US$ Million)
Table 36. North America Irritable Bowel Syndrome Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. North America Irritable Bowel Syndrome Drug Market Size by Country (2018-2024) & (US$ Million)
Table 38. North America Irritable Bowel Syndrome Drug Market Size by Country (2024-2029) & (US$ Million)
Table 39. Europe Irritable Bowel Syndrome Drug Market Size by Type (2018-2024) & (US$ Million)
Table 40. Europe Irritable Bowel Syndrome Drug Market Size by Type (2024-2029) & (US$ Million)
Table 41. Europe Irritable Bowel Syndrome Drug Market Size by Application (2018-2024) & (US$ Million)
Table 42. Europe Irritable Bowel Syndrome Drug Market Size by Application (2024-2029) & (US$ Million)
Table 43. Europe Irritable Bowel Syndrome Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Europe Irritable Bowel Syndrome Drug Market Size by Country (2018-2024) & (US$ Million)
Table 45. Europe Irritable Bowel Syndrome Drug Market Size by Country (2024-2029) & (US$ Million)
Table 46. China Irritable Bowel Syndrome Drug Market Size by Type (2018-2024) & (US$ Million)
Table 47. China Irritable Bowel Syndrome Drug Market Size by Type (2024-2029) & (US$ Million)
Table 48. China Irritable Bowel Syndrome Drug Market Size by Application (2018-2024) & (US$ Million)
Table 49. China Irritable Bowel Syndrome Drug Market Size by Application (2024-2029) & (US$ Million)
Table 50. Asia Irritable Bowel Syndrome Drug Market Size by Type (2018-2024) & (US$ Million)
Table 51. Asia Irritable Bowel Syndrome Drug Market Size by Type (2024-2029) & (US$ Million)
Table 52. Asia Irritable Bowel Syndrome Drug Market Size by Application (2018-2024) & (US$ Million)
Table 53. Asia Irritable Bowel Syndrome Drug Market Size by Application (2024-2029) & (US$ Million)
Table 54. Asia Irritable Bowel Syndrome Drug Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 55. Asia Irritable Bowel Syndrome Drug Market Size by Region (2018-2024) & (US$ Million)
Table 56. Asia Irritable Bowel Syndrome Drug Market Size by Region (2024-2029) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Irritable Bowel Syndrome Drug Market Size by Type (2018-2024) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Irritable Bowel Syndrome Drug Market Size by Type (2024-2029) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Irritable Bowel Syndrome Drug Market Size by Application (2018-2024) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Irritable Bowel Syndrome Drug Market Size by Application (2024-2029) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Irritable Bowel Syndrome Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 62. Middle East, Africa, and Latin America Irritable Bowel Syndrome Drug Market Size by Country (2018-2024) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Irritable Bowel Syndrome Drug Market Size by Country (2024-2029) & (US$ Million)
Table 64. Ironwood Pharmaceuticals Company Details
Table 65. Ironwood Pharmaceuticals Business Overview
Table 66. Ironwood Pharmaceuticals Irritable Bowel Syndrome Drug Product
Table 67. Ironwood Pharmaceuticals Revenue in Irritable Bowel Syndrome Drug Business (2018-2024) & (US$ Million)
Table 68. Ironwood Pharmaceuticals Recent Developments
Table 69. Bausch Health Company Details
Table 70. Bausch Health Business Overview
Table 71. Bausch Health Irritable Bowel Syndrome Drug Product
Table 72. Bausch Health Revenue in Irritable Bowel Syndrome Drug Business (2018-2024) & (US$ Million)
Table 73. Bausch Health Recent Developments
Table 74. Takeda Company Details
Table 75. Takeda Business Overview
Table 76. Takeda Irritable Bowel Syndrome Drug Product
Table 77. Takeda Revenue in Irritable Bowel Syndrome Drug Business (2018-2024) & (US$ Million)
Table 78. Takeda Recent Developments
Table 79. Sebela Pharmaceuticals Company Details
Table 80. Sebela Pharmaceuticals Business Overview
Table 81. Sebela Pharmaceuticals Irritable Bowel Syndrome Drug Product
Table 82. Sebela Pharmaceuticals Revenue in Irritable Bowel Syndrome Drug Business (2018-2024) & (US$ Million)
Table 83. Sebela Pharmaceuticals Recent Developments
Table 84. Allergan Company Details
Table 85. Allergan Business Overview
Table 86. Allergan Irritable Bowel Syndrome Drug Product
Table 87. Allergan Revenue in Irritable Bowel Syndrome Drug Business (2018-2024) & (US$ Million)
Table 88. Allergan Recent Developments
Table 89. Research Programs/Design for This Report
Table 90. Key Data Information from Secondary Sources
Table 91. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Irritable Bowel Syndrome Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Irritable Bowel Syndrome Drug Market Share by Type: 2022 VS 2029
Figure 3. IBS-D Drugs Features
Figure 4. IBS-C Drugs Features
Figure 5. Others Features
Figure 6. Global Irritable Bowel Syndrome Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Irritable Bowel Syndrome Drug Market Share by Application: 2022 VS 2029
Figure 8. Women Case Studies
Figure 9. Men Case Studies
Figure 10. Irritable Bowel Syndrome Drug Report Years Considered
Figure 11. Global Irritable Bowel Syndrome Drug Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Irritable Bowel Syndrome Drug Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Irritable Bowel Syndrome Drug Market Share by Region: 2022 VS 2029
Figure 14. Global Irritable Bowel Syndrome Drug Market Share by Players in 2022
Figure 15. Global Top Irritable Bowel Syndrome Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Irritable Bowel Syndrome Drug as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Irritable Bowel Syndrome Drug Revenue in 2022
Figure 17. North America Irritable Bowel Syndrome Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Irritable Bowel Syndrome Drug Market Share by Type (2018-2029)
Figure 19. North America Irritable Bowel Syndrome Drug Market Share by Application (2018-2029)
Figure 20. North America Irritable Bowel Syndrome Drug Market Share by Country (2018-2029)
Figure 21. United States Irritable Bowel Syndrome Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Irritable Bowel Syndrome Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Irritable Bowel Syndrome Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 24. Europe Irritable Bowel Syndrome Drug Market Share by Type (2018-2029)
Figure 25. Europe Irritable Bowel Syndrome Drug Market Share by Application (2018-2029)
Figure 26. Europe Irritable Bowel Syndrome Drug Market Share by Country (2018-2029)
Figure 27. Germany Irritable Bowel Syndrome Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. France Irritable Bowel Syndrome Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. U.K. Irritable Bowel Syndrome Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Italy Irritable Bowel Syndrome Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Russia Irritable Bowel Syndrome Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Nordic Countries Irritable Bowel Syndrome Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. China Irritable Bowel Syndrome Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 34. China Irritable Bowel Syndrome Drug Market Share by Type (2018-2029)
Figure 35. China Irritable Bowel Syndrome Drug Market Share by Application (2018-2029)
Figure 36. Asia Irritable Bowel Syndrome Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 37. Asia Irritable Bowel Syndrome Drug Market Share by Type (2018-2029)
Figure 38. Asia Irritable Bowel Syndrome Drug Market Share by Application (2018-2029)
Figure 39. Asia Irritable Bowel Syndrome Drug Market Share by Region (2018-2029)
Figure 40. Japan Irritable Bowel Syndrome Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. South Korea Irritable Bowel Syndrome Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. China Taiwan Irritable Bowel Syndrome Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Southeast Asia Irritable Bowel Syndrome Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. India Irritable Bowel Syndrome Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Australia Irritable Bowel Syndrome Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Irritable Bowel Syndrome Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Irritable Bowel Syndrome Drug Market Share by Type (2018-2029)
Figure 48. Middle East, Africa, and Latin America Irritable Bowel Syndrome Drug Market Share by Application (2018-2029)
Figure 49. Middle East, Africa, and Latin America Irritable Bowel Syndrome Drug Market Share by Country (2018-2029)
Figure 50. Brazil Irritable Bowel Syndrome Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Mexico Irritable Bowel Syndrome Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Turkey Irritable Bowel Syndrome Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia Irritable Bowel Syndrome Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Israel Irritable Bowel Syndrome Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. GCC Countries Irritable Bowel Syndrome Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Ironwood Pharmaceuticals Revenue Growth Rate in Irritable Bowel Syndrome Drug Business (2018-2024)
Figure 57. Bausch Health Revenue Growth Rate in Irritable Bowel Syndrome Drug Business (2018-2024)
Figure 58. Takeda Revenue Growth Rate in Irritable Bowel Syndrome Drug Business (2018-2024)
Figure 59. Sebela Pharmaceuticals Revenue Growth Rate in Irritable Bowel Syndrome Drug Business (2018-2024)
Figure 60. Allergan Revenue Growth Rate in Irritable Bowel Syndrome Drug Business (2018-2024)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries